Skip Navigation



Annals of Oncology Advance Access published online on April 13, 2007
Annals of Oncology, doi:10.1093/annonc/mdm106
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
18/7/1190    most recent
mdm106v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Figueras, J
Right arrow Articles by Mojal, S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Figueras, J
Right arrow Articles by Mojal, S
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2007 European Society for Medical Oncology

Effect of subcentimeter nonpositive resection margin on hepatic recurrence in patients undergoing hepatectomy for colorectal liver metastases. Evidences from 663 liver resections

J Figueras1,*, F Burdio2,{dagger}, E Ramos2, J Torras2, L Llado2, S Lopez-Ben1, A Codina-Barreras1 and S Mojal3

1 Department of Surgery, Hospital de Girona "Josep Trueta", Girona
2 Department of Surgery, Bellvitge Hospital, Barcelona
3 Assessoria Metodològica en Investigació Biomèdica, Institut Municipal Investigacions Mediques, Barcelona, Spain

* Correspondence to: Dr J. Figueras, Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, Hospital de Girona "Dr Josep Trueta", Crta de França s/n 17007 Girona, Spain. Tel: +34 972940256; Fax: +34 972940270; E-mail: info{at}jfigueras.net

Objective: To elucidate if a nonpositive <1-cm resection margin has any effect on hepatic recurrence in patients undergoing liver resection for colorectal liver metastases.

Patients and methods: Six hundred and nine patients underwent 663 liver resections. Patients with positive margin were excluded from the analysis. Two groups were studied: group A, <1-cm resection margin and group B, ≥1-cm resection margin.

Results: A total of 545 liver resections in 523 patients were carried out with nonpositive resection margins. With a median follow-up of 25 months, the 5-year cumulative hepatic recurrence reached 54% in group A (n = 206) and 41% in group B (n = 339). Factors associated with hepatic recurrence were synchronic metastases (P = 0.0015), bilobar (P < 0.001), two or more metastases (P < 0.001), margin <1 cm (P = 0.0123) and extrahepatic disease (P = 0.0037). A strong correlation between resection margin and number of metastases was confirmed (P < 0.001). At multivariate analysis only two factors were independent predictors of hepatic recurrence: multinodular disease in the liver specimen [≥4 metastases hazard ratio (HR) = 3.45; 95% confidence interval (CI): 2.2–5.38; P < 0.001] and extrahepatic disease at hepatectomy (HR = 1.58; 95% CI: 1.58–3.32).

Conclusion: Subcentimeter nonpositive resection margins do not directly influence hepatic recurrence in patients undergoing hepatectomy for colorectal liver metastases.

colorectal cancer, hepatectomy, liver metastases, liver neoplasms, liver surgery, resection margin

{dagger} Present address: Department of Surgery, Hospital del Mar, Barcelona, Spain

Received for publication December 17, 2006. Revision received February 16, 2007. Accepted for publication February 19, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 JCOHome page
G. J. Poston, J. Figueras, F. Giuliante, G. Nuzzo, A. F. Sobrero, J.-F. Gigot, B. Nordlinger, R. Adam, T. Gruenberger, M. A. Choti, et al.
Urgent Need for a New Staging System in Advanced Colorectal Cancer
J. Clin. Oncol., October 10, 2008; 26(29): 4828 - 4833.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.